An establishment or an authorised body may transfer gene therapy preparations or xenogenic cell therapy preparations to another establishment or authorised body with a view to their preparation, storage and distribution by this second establishment or body.
When transferred for distribution, the gene therapy preparations or xenogenic cell therapy preparations must comply with the rules of good practice provided for in Article L. 5121-5 and the requirements mentioned in the authorisation provided for in 12° and 13° of Article L. 5121-1.